Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ADXS

Advaxis

$0.36

-0.0071 (-1.93%)

, AMGN

Amgen

$197.47

1.06 (0.54%)

17:00
12/13/18
12/13
17:00
12/13/18
17:00
Hot Stocks
Advaxis receives notice of termination from Amgen relating to ADXS-NEO program »

On December 10, Advaxis…

ADXS

Advaxis

$0.36

-0.0071 (-1.93%)

AMGN

Amgen

$197.47

1.06 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

PLX

Protalix

$0.41

0.0032 (0.78%)

05:55
12/13/18
12/13
05:55
12/13/18
05:55
Conference/Events
Protalix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PLX

Protalix

$0.41

0.0032 (0.78%)

04:55
12/13/18
12/13
04:55
12/13/18
04:55
Conference/Events
Protalix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

Tuesday
PLX

Protalix

$0.41

-0.0206 (-4.81%)

15:16
12/11/18
12/11
15:16
12/11/18
15:16
Conference/Events
Protalix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
OVID

Ovid Therapeutics

$3.31

-0.07 (-2.07%)

16:23
12/10/18
12/10
16:23
12/10/18
16:23
Hot Stocks
Breaking Hot Stocks news story on Ovid Therapeutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$7.41

0.09 (1.23%)

09:57
12/10/18
12/10
09:57
12/10/18
09:57
Periodicals
Intec Pharma expects to earn revenue from Parkinson's pill in 2019, Reuters says »

Intec Pharma, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
BYSI

BeyondSpring

$24.35

-0.15 (-0.61%)

11:47
12/06/18
12/06
11:47
12/06/18
11:47
Recommendations
BeyondSpring analyst commentary at H.C. Wainwright »

BeyondSpring delivers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$3.30

-0.79 (-19.32%)

08:04
12/06/18
12/06
08:04
12/06/18
08:04
Hot Stocks
Ovid Therapeutics to move into Phase 3 OV101 trial in pediatric patients »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYSI

BeyondSpring

$24.50

(0.00%)

07:47
12/06/18
12/06
07:47
12/06/18
07:47
Hot Stocks
BeyondSpring announces Phase 3 Study 105 meets primary endpoint »

BeyondSpring announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$7.75

0.15 (1.97%)

, NVS

Novartis

$90.76

-0.79 (-0.86%)

07:06
12/06/18
12/06
07:06
12/06/18
07:06
Hot Stocks
Intec Pharma to continue development collaboration for Novartis' Accordion Pill »

Intec Pharma (NTEC)…

NTEC

Intec Pharma

$7.75

0.15 (1.97%)

NVS

Novartis

$90.76

-0.79 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.